Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James C. Gale currently holds 394,624 shares of INDEVUS PHARMACEUTICALS INC (IDEV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James C. Gale has been a net seller of IDEV stock. They have purchased $351.8K and sold $98.9M worth of shares.
James C. Gale's most recent insider trade was on May 31, 2019, when they purchased 20,000 shares at $0.66 per share.
James C. Gale serves as Executive at INDEVUS PHARMACEUTICALS INC (IDEV). They have executed 198 insider transactions totaling $99.2M over their tenure at the company.
James C. Gale holds the position of Executive at INDEVUS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 22 years and currently hold a stake valued at $0.
James C. Gale has shown a selling trading pattern, with $351.8K in total purchases and $98.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James C. Gale was on Apr 29, 2015, when they sold $23.0M worth of PFNX shares. This transaction involved 1,576,808 shares at $14.57 per share.
James C. Gale currently owns 394,624 shares of INDEVUS PHARMACEUTICALS INC (IDEV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James C. Gale's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James C. Gale has 198 Form 4 filings on record as an insider at INDEVUS PHARMACEUTICALS INC.
Set alerts for James C. Gale and 40,000+ other insiders.